Liquid biopsy in lung cancer: precision medicine and MRD

In this podcast, we’ll be discussing the use of liquid biopsy in lung cancer, with Professor Klaus Pantel of University Medical Center Hamburg-Eppendorf, in Hamburg, Germany. At the European Lung Cancer Congress (ELCC) 2023, we spoke with Professor Pantel about possible areas where liquid biopsy could be useful, such as clinical trial recruitment, as well as practical considerations for the use of liquid biopsies, and the role of MRD status in the management of non-small cell lung cancer.

The post Liquid biopsy in lung cancer: precision medicine and MRD appeared first on VJOncology.